NRx pharmaceuticals files New Drug Application for ketamine depression treatment

Green Market Report
By Adam JacksonMar 19, 2025, 2:03 pm181 ptsTrendingTop
NRx Pharmaceuticals (NASDAQ: NRXP) filed a New Drug Application for its intravenous ketamine treatment for suicidal depression as it tries to expand its psychiatric clinic network, the company said Monday. The company, which focuses on treatments for central nervous system disorders including suicidal…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Are Police In Memphis Overcharging Drivers Caught With Small Amounts Of Marijuana? 57

Hemp Farmers Say Texas Bill To Rein In Intoxicating Cannabinoid Products Could Destroy State Industry 42

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.